InsiderTrades.com logo

LUMO Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 25.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Lumos Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Lumos Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lumos Pharma Share Price & Price History

Current Price: $4.34
Price Change: +0.30 (1.20%)
As of 12/12/2024 01:00 AM ET

This chart shows the closing price history over time for LUMO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Lumos Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/6/2024John C MckewInsiderSell3,407$1.89$6,439.2312,653View SEC Filing Icon  
4/3/2024John C MckewInsiderSell2,214$2.77$6,132.7817,153View SEC Filing Icon  
2/6/2024John C MckewInsiderSell438$3.03$1,327.1418,403View SEC Filing Icon  
8/2/2023John C MckewInsiderSell3,407$3.21$10,936.4718,707View SEC Filing Icon  
4/4/2023John C MckewInsiderSell2,214$3.27$7,239.7823,207View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Lumos Pharma (NASDAQ:LUMO)

33.99% of Lumos Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LUMO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Lumos Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/22/2024Private Advisor Group LLC744,513$2.88M0.0%+2,380.6%9.173%Search for SEC Filing on Google Icon
5/16/2024Blackstone Inc.78,624$0.22M0.0%-75.9%0.968%Search for SEC Filing on Google Icon
2/15/2024Blackstone Inc.326,552$1.04M0.0%-30.2%4.128%Search for SEC Filing on Google Icon
2/6/2024Private Advisor Group LLC16,013$51K0.0%-20.0%0.202%Search for SEC Filing on Google Icon
11/7/2023Greenwich Wealth Management LLC76,341$0.25M0.0%+55.8%0.961%Search for SEC Filing on Google Icon
11/3/2023Private Advisor Group LLC20,013$66K0.0%+42.8%0.252%Search for SEC Filing on Google Icon
10/27/2023Marquette Asset Management LLC25,760$85K0.0%-17.1%0.324%Search for SEC Filing on Google Icon
10/27/2023Acuitas Investments LLC125,242$0.41M0.2%-18.6%1.577%Search for SEC Filing on Google Icon
8/10/2023Private Advisor Group LLC14,013$46K0.0%-30.0%0.172%Search for SEC Filing on Google Icon
7/31/2023Greenwich Wealth Management LLC49,002$0.16M0.0%+63.2%0.600%Search for SEC Filing on Google Icon
5/1/2023Marquette Asset Management LLC31,088$0.10M0.0%+47.9%0.379%Search for SEC Filing on Google Icon
4/24/2023Greenwich Wealth Management LLC30,028$99K0.0%N/A0.366%Search for SEC Filing on Google Icon
2/10/2023K2 Principal Fund L.P.15,836$57K0.0%-71.7%0.189%Search for SEC Filing on Google Icon
1/18/2023Private Advisor Group LLC20,013$72K0.0%+17.6%0.238%Search for SEC Filing on Google Icon
1/12/2023Marquette Asset Management LLC21,020$76K0.0%+57.9%0.250%Search for SEC Filing on Google Icon
10/14/2022Private Advisor Group LLC17,013$0.15M0.0%-37.0%0.203%Search for SEC Filing on Google Icon
8/15/2022Opaleye Management Inc.21,520$0.17M0.1%N/A0.257%Search for SEC Filing on Google Icon
7/26/2022Key Financial Inc10,916$84K0.0%N/A0.130%Search for SEC Filing on Google Icon
7/22/2022Urban Wealth Management LLC3,490$27K0.1%N/A0.042%Search for SEC Filing on Google Icon
2/15/2022Lion Point Capital LP51,205$0.35M0.1%-87.4%0.613%Search for SEC Filing on Google Icon
2/4/2022Envestnet Asset Management Inc.10,368$72K0.0%N/A0.124%Search for SEC Filing on Google Icon
2/2/2022PVG Asset Management Corp10,175$71K0.3%N/A0.122%Search for SEC Filing on Google Icon
1/14/2022Investors Financial Group LLC30,600$0.21M0.1%-11.6%0.366%Search for SEC Filing on Google Icon
11/15/2021Minerva Advisors LLC34,015$0.32M0.2%N/A0.407%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC286,412$2.72M0.0%-6.3%3.427%Search for SEC Filing on Google Icon
11/12/2021Connor Clark & Lunn Investment Management Ltd.33,427$0.32M0.0%+4.7%0.400%Search for SEC Filing on Google Icon
10/21/2021Investors Financial Group LLC34,600$0.33M0.2%+16.9%0.414%Search for SEC Filing on Google Icon
10/12/2021Marquette Asset Management LLC13,234$0.13M0.0%+48.4%0.158%Search for SEC Filing on Google Icon
8/16/2021State Street Corp11,237$0.11M0.0%N/A0.134%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Lumos Pharma logo
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas.
Read More on Lumos Pharma

Today's Range

Now: $4.34
Low: $4.34
High: $4.34

50 Day Range

MA: $4.34
Low: $4.30
High: $4.41

52 Week Range

Now: $4.34
Low: $1.46
High: $4.58

Volume

N/A

Average Volume

100,335 shs

Market Capitalization

$37.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74

Who are the company insiders with the largest holdings of Lumos Pharma?

Lumos Pharma's top insider shareholders include:
  1. John C Mckew (Insider)
Learn More about top insider investors at Lumos Pharma.